🔎 Trials Near Me

Utama › Penyakit Paru-paru › Pennsylvania

Kajian klinikal Penyakit Paru-paru di Pennsylvania

21 kajian untuk Penyakit Paru-paru sedang mencari peserta di lokasi di Pennsylvania.

Bandar di Pennsylvania

Teks kajian rasmi (Bahasa Inggeris)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Pittsburgh
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Alliance Cancer Specialists, Sellersville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06765109

A Study of COVID-19 Vaccine(s) in Children and Adults

  • DM Clinical Research, Philadelphia
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
Umur 5 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07798648

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Preferred Primary Care Physicians, Uniontown
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • TRC, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
  • UPMC Division of Infectious Disease Clinic, Pittsburgh
  • dan 5 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07013474

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Clinical Research Associates of Central PA, DuBois
Mengambil pesertaFasa 2
Umur 40 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07759245

American Lung Association (ALA) Lung Health Cohort

  • Temple University, Philadelphia
  • University of Pittsburg-Emphysema/COPD Research Center, Pittsburgh
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 25 hingga 35 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT04543461

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Allegheny Health Network, Pittsburgh
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • Clinical Research Associates of Central PA, LLC, DuBois
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06977581

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Philadelphia
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06572384

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • USO - Alliance Cancer Specialists, PC, Horsham
  • Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • Temple University, Philadelphia
  • University of Pittsburgh, Pittsburgh
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07059091

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  • Clinical Research Associates of Central PA, DuBois
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07284602

Deep Functional Phenotyping of the ALA Lung Health Cohort

  • University of Pittsburgh - Emphysema/COPD Research Center, Pittsburgh
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 25 hingga 35 · Semua jantina · Dikemas kini 17 Jul 2026 · NCT06177717

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • Allegheny General Hospital, Natrona Heights
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 26 Jun 2026 · NCT04614103

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

  • UPMC Hillman Cancer Center, Pittsburgh
Mengambil pesertaFasa 1/2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 11 Jun 2026 · NCT05361174

Data Collection Using Eko Digital Devices in a Clinical Setting

  • Jefferson Einstein Philadelphia Hospital, Philadelphia
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 26 Mei 2026 · NCT07227376

Supporting Evidence-based Responses to Emotional Needs in Emphysema

  • University of Pennsylvania, Philadelphia
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jan 2026 · NCT06600126

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • UPMC Hillman Cancer Center, Pittsburgh
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Dis 2025 · NCT06619561

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • Temple University Hospital-Temple Lung Center, Philadelphia
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 12 Nov 2025 · NCT05975983

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

  • University of Pittsburgh Medical Centre, Pittsburgh
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jul 2024 · NCT02735707

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.